New data from Reach2HD trial presented at American Neurological Association Annual Meeting October 18, 2016
Prana’s PBT2 presented at the Huntington’s Disease Society of America National Convention: Prana’s ‘Reach2HD’ Phase II trial on track July 17, 2013
